Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-29

FDA Approved: ENOBY — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved ENOBY (denosumab-qbde) from Hikma Pharmaceuticals USA Inc. via an original biologics license application. ENOBY is a denosumab product indicated fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENOBY (DENOSUMAB-QBDE)

Snippet

ORIG AP for ENOBY (DENOSUMAB-QBDE)